Global Blood Therapeutics Prices A $150.0 Million Common Stock Public Offering
December 07, 2018 at 10:25 AM EST
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $150.0 million.
